Arvinas, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics, Inc. |
$2.25 | $291.95 M | -3.13 | 54 | $0 |
CCCC
C4 Therapeutics, Inc. |
$3.75 | $320.64 M | -1.97 | 145 | $20.76 M |
CRNX
Crinetics Pharmaceuticals, Inc. |
$35.58 | $3.53 B | -11.86 | 290 | $4.01 M |
FHTX
Foghorn Therapeutics Inc. |
$4.26 | $332.53 M | -2.73 | 116 | $34.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.55 | $243.38 M | -1.59 | 133 | $0 |
IPSC
Century Therapeutics, Inc. |
$0.92 | $244.54 M | -1.32 | 152 | $2.24 M |
KURA
Kura Oncology, Inc. |
$7.26 | $1.66 B | -10.03 | 142 | $0 |
KYMR
Kymera Therapeutics, Inc. |
$40.06 | $2.02 B | -13.13 | 184 | $78.59 M |
NRIX
Nurix Therapeutics, Inc. |
$18.57 | $930.10 M | -5.89 | 284 | $76.99 M |
PLRX
Pliant Therapeutics, Inc. |
$11.25 | $672.63 M | -3.9 | 166 | $1.58 M |
RARE
Ultragenyx Pharmaceutical Inc. |
$39.99 | $3.44 B | -5.21 | 1276 | $434.25 M |
RLAY
Relay Therapeutics, Inc. |
$4.35 | $1.05 B | -3 | 294 | $25.55 M |
RVMD
Revolution Medicines, Inc. |
$39.79 | $6.66 B | -10.51 | 490 | $11.58 M |
STOK
Stoke Therapeutics, Inc. |
$8.66 | $774.50 M | -6.14 | 110 | $8.78 M |
STTK
Shattuck Labs, Inc. |
$1.13 | $333.81 M | -3.64 | 75 | $1.66 M |